Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-22.58%
operating margin TTM
-8.18%
revenue TTM
1.03 Billion
revenue per share TTM
12.42$
valuation ratios | |
|---|---|
| pe ratio | -35.14 |
| peg ratio | 0.27 |
| price to book ratio | -37.50 |
| price to sales ratio | 8.22 |
| enterprise value multiple | -60.57 |
| price fair value | -37.50 |
profitability ratios | |
|---|---|
| gross profit margin | 77.84% |
| operating profit margin | -8.18% |
| pretax profit margin | -28.49% |
| net profit margin | -22.58% |
| return on assets | -6.51% |
| return on equity | 99.84% |
| return on capital employed | -3.48% |
liquidity ratios | |
|---|---|
| current ratio | 2.44 |
| quick ratio | 2.36 |
| cash ratio | 0.90 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 150.50 |
| operating cycle | 247.55 |
| days of payables outstanding | 50.75 |
| cash conversion cycle | 196.80 |
| receivables turnover | 3.76 |
| payables turnover | 7.19 |
| inventory turnover | 2.43 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | -2.19 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 1.84 |
| interest coverage | -0.98 |
| cash flow to debt ratio | -0.55 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.20 |
| cash per share | 22.93 |
| operating cash flow per share | -2.64 |
| free cash flow operating cash flow ratio | 1.21 |
| cash flow coverage ratios | -0.55 |
| short term coverage ratios | -0.76 |
| capital expenditure coverage ratio | -4.73 |
Frequently Asked Questions
When was the last time PTC Therapeutics, Inc. (NASDAQ:PTCT) reported earnings?
PTC Therapeutics, Inc. (PTCT) published its most recent earnings results on 07-05-2026.
What is PTC Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. PTC Therapeutics, Inc. (NASDAQ:PTCT)'s trailing twelve months ROE is 99.84%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. PTC Therapeutics, Inc. (PTCT) currently has a ROA of -6.51%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PTCT's net profit margin stand at?
PTCT reported a profit margin of -22.58% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PTCT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.44 in the most recent quarter. The quick ratio stood at 2.36, with a Debt/Eq ratio of -2.19.